Search details
1.
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
Hematol Oncol
; 40(1): 31-39, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34694649
2.
Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi.
Br J Haematol
; 156(3): 346-53, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-22145911
3.
Texture analysis and multiple-instance learning for the classification of malignant lymphomas.
Comput Methods Programs Biomed
; 185: 105153, 2020 Mar.
Article
in English
| MEDLINE | ID: mdl-31678792
4.
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.
Leuk Lymphoma
; 51(3): 422-9, 2010 Mar.
Article
in English
| MEDLINE | ID: mdl-20038237
5.
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy.
Hematol Oncol
; 25(4): 189-97, 2007 Dec.
Article
in English
| MEDLINE | ID: mdl-17654762
Results
1 -
5
de 5
1
Next >
>>